Psychiatry and Psychology [F] » Mental Disorders [F03] » Schizophrenia Spectrum and Other Psychotic Disorders » Psychotic Disorders
Description
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) MeSH
Hierarchy View
Subtype Terms (1)
Psychoses, Substance-Induced
2 approved drugs
Approved Indicated Drugs (16)
Phase 4 Indicated Drugs (69)
Phase 3 Indicated Drugs (15)
Phase 1 Indicated Drugs (8)
Other Experimental Indicated Drugs (26)
Organization Involved with Phase 4 Indications (153)
Abarbanel Mental Health Center
Allocated inheritance from Elizabeth Stevn and Niels Rindom, Denmark
American Psychiatric Association
Beer Yaakov and Ness Ziona Mental Health Center
Brain & Behavior Research Foundation
Center Abarbanel Mental Health
Centro de Investigación Biomédica en Red (CIBER)
German Research Network On Schizophrenia
Handok Pharmaceuticals Co., Ltd.
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Medical University of South Carolina
Michael J. Gill Mental Health Clinic
National Health and Medical Research Council, Australia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Mental Health (NIMH)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
National Research Council of Thailand
North Suffolk Mental Health Association
Provincial Health Services Authority
Ram Manohar Lohia Insitute of Medical Sciences
Research Foundation for Mental Hygiene, Inc.
Sha'ar Menashe Mental Health Center
Stanley Medical Research Institute
State University of New York, Buffalo
State University of New York, Syracuse
Technical University of Munich
The Ian Douglas Bebensee Foundation
The Massachusetts Mental Health Center
The Research Council for Health and Disease, Denmark
The University of Texas, Dallas
Universidad Nacional de Rosario
University of British Columbia
University of California, Berkeley
University of California, San Diego
University of California, San Francisco
University of Medicine and Dentistry of New Jersey
University of Missouri, Kansas City
University of North Carolina at Chapel Hill
University of Southern Denmark
Veterans Medical Research Foundation
Washington University in St. Louis
Organization Involved with Phase 3 Indications (63)
Case Western Reserve University
Center for Medicinal Cannabis Research
Christian Medical College, Vellore, India
Clinic for Psychiatric Disorders
Clinic for Psychiatric Disorders, Dr Laza Lazarevic
Cognitive Research Corporation
Geestelijke gezondheidszorg voor mensen in Eindhoven en omgeving
Johanne and Einar Eilertsen's research fund
Josef and Haldis Andresen's legacy
National Institute of Mental Health and Neuro Sciences, India
Scandinavian Society for Psychopharmacology
Shanghai Pudong Nanhui Mental Health Center
Shanghai Xuhui District Mental Health Center
Shenzhen Fushan Biotech Co., Ltd.
Organization Involved with Phase 2 Indications (65)
Atlanta Center for Medical Research
Danish Center for Sleep Medicine
Danish Research Foundation, Copenhagen
Foundation of Hope, North Carolina
Karwan e Hayat, Karachi, Pakistan
Katholieke Universiteit Leuven
National University of Ireland
Northern Ontario School of Medicine
Pakistan Institute of Living and Learning
Rawalpindi Medical College, Pakistan
Russian Academy of Medical Sciences
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (23)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.